EMBECTA CORP. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.1 USD | +1.99% |
|
-9.79% | -31.14% |
| 05-16 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
| 05-09 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
Presenter SpeechMatthew O'Brien (Analysts)Everybody, thank you so much for joining us during o...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes. The Company has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The Company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels.
Calendar
05/06/2024
- Jefferies Global Healthcare Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.99
USD
Average target price
15
USD
Spread / Average Target
+15.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -31.14% | 749M | |
| -5.61% | 181B | |
| -0.65% | 108B | |
| -6.24% | 66.57B | |
| +3.17% | 49.95B | |
| +6.50% | 43.84B | |
| +4.91% | 41.71B | |
| +22.31% | 31.59B | |
| +14.45% | 25.3B | |
| -6.18% | 23.94B |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Transcript : Embecta Corp. Presents at Piper Sandler Ophthalmology and Diabetes Symposium, May-25-2022 12
